384 Participants Needed

MOMI PODS for Postpartum Health

SL
SS
Overseen BySandra Solove, MA
Age: Any Age
Sex: Female
Trial Phase: Academic
Sponsor: Ohio State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the MOMI PODS treatment for postpartum health?

The MOMI PODS program shows promise in improving postpartum health by integrating outpatient care into pediatric structures, which increases access to healthcare and promotes better health outcomes for postpartum individuals, especially those who are publicly insured.12345

What safety data exists for the MOMI PODS program for postpartum health?

The MOMI PODS program is designed to improve postpartum care by integrating it into pediatric care structures, focusing on increasing access to healthcare for postpartum individuals. While the program aims to mitigate maternal health risks, the available research does not provide specific safety data or adverse event information related to the program itself.14678

How is the MOMI PODS treatment different from other postpartum health treatments?

MOMI PODS is unique because it integrates postpartum care into pediatric care structures, improving access to primary care and community resources for postpartum individuals, especially those who are publicly insured. This approach focuses on mitigating maternal health risks by providing a collaborative care model involving multiple healthcare disciplines, which is not typically seen in standard postpartum care.19101112

What is the purpose of this trial?

The investigator's long-term goal is to mitigate pregnancy-related mortality (PRM) risk by systematically delivering integrated clinical and supportive care that is effective, equitable, and scalable. The investigator's central hypothesis is that the Multi-modal Maternal Infant Perinatal Outpatient Delivery System (MOMI PODS) will mitigate postpartum (PP) risk and reduce disparities in PP risk by improving biopsychosocial profiles and facilitating access to evidence-based clinical and supportive care. To test this hypothesis, the investigators will conduct a hybrid type 1 randomized controlled trial (RCT) of MOMI PODS versus enhanced usual care (EUC, which we will term MOMI CARE) among a total sample of 384 mother-infant dyads (192/group) following pregnancy affected by a cardiometabolic and/or mental health condition. The investigators will enroll participants on PP day 1 and collect data at baseline and 6 months and 1 year PP. The investigators will collect implementation and service data across sites.

Eligibility Criteria

The MOMI Study is for new mothers and their infants, specifically those affected by conditions like metabolic syndrome or postpartum depression/anxiety. Participants are enrolled on the first day after giving birth and will be followed up with at 6 months and 1 year postpartum.

Inclusion Criteria

Index pregnancy affected by gestational diabetes mellitus (GDM)
Index pregnancy affected by eclampsia
Index pregnancy affected by hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome
See 7 more

Exclusion Criteria

Presence of a pre-existing, community driven MOMI PODS referral that has already been scheduled
Maternal history of syncope during venipuncture
Maternal history of a seizure disorder
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 day
1 visit (in-person)

Treatment

Participants receive either MOMI PODS or Enhanced Usual Care (EUC) interventions, focusing on postpartum care and reducing disparities in postpartum risk.

12 months
Regular visits throughout the postpartum year

Follow-up

Participants are monitored for safety and effectiveness after treatment, with data collection at 6 months and 1 year postpartum.

6 months
Data collection at 6 months and 12 months postpartum

Treatment Details

Interventions

  • Enhanced Usual Care (EUC)
  • MOMI PODS
Trial Overview This study tests a care system called MOMI PODS against Enhanced Usual Care (EUC), aiming to improve health outcomes for mother-infant pairs. It's a randomized controlled trial where participants are randomly assigned to one of the two groups.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
MOMI PODS is an innovative, dyadic model of PP primary care. Informed by the Chronic Care Model (CCM) and extensive stakeholder engagement, the MOMI PODS suite of services addresses four primary domains, with a focus on preventing PRM and eliminating SES, racial, and ethnic disparities in PRM. First, MOMI PODS is a dyadic model of care, with mothers and infants cared for in tandem throughout the PP year, and beyond. Second, MOMI PODS was strategically designed to facilitate a coordinated obstetric to PP primary care transition. Third, MOMI PODS is delivered in a way that promotes tailored, evidence-based care informed by the obstetric history. Fourth, MOMI PODS systematically integrates clinical and supportive care to concurrently address clinical and psychosocial needs, with MOMI PODS engagement extending beyond the typical referral process to facilitate direct access to needed resources and empower patients.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
Usual care will be enhanced in by implementing an enhanced PP care handoff as an adaptation of typical institutional discharge procedures. Specifically, under current processes, birthing parents are asked to provide the name of their infant's pediatrician during the L\&D admission, must provide the name of their infant's pediatrician prior to discharge, and are assisted with identifying a pediatrician throughout this process as needed. Alternatively, under current processes, mothers are reminded to seek PP care but not required to identify the location of care or assisted with doing so. As a component of EUC, we'll provide participants with information about our 7 EUC sites and actively assist with identifying their preferred location of care and scheduling PP care. Our research team will also engage with EUC recipients throughout the study period to encourage engagement and study retention through small care packages and hand-written notes, as well as data collection.

MOMI PODS is already approved in United States for the following indications:

🇺🇸
Approved in United States as MOMI PODS for:
  • Postpartum care for mothers with cardiometabolic and/or mental health conditions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials
891
Recruited
2,659,000+

Findings from Research

The MOMI PODS program aims to improve postpartum care by integrating it into pediatric care systems, specifically targeting publicly insured individuals to enhance access to primary care and community resources.
This innovative approach has shown promise in increasing healthcare utilization and addressing maternal morbidity risk factors, although challenges such as provider capacity and data tracking were encountered during implementation.
Developing a multimodal maternal infant perinatal outpatient delivery system: the MOMI PODS program.Bose Brill, S., Juckett, LA., D'Amico Gordon, R., et al.[2023]
In a study of 1,892 doula-supported adolescent births from 2000 to 2013, improved health outcomes and lower intervention rates were observed compared to national statistics for adolescent deliveries in the U.S.
The findings support the effectiveness of doula care in enhancing maternal and infant health outcomes, particularly for marginalized and medically underserved communities, highlighting its potential to reduce health inequities among young mothers.
Outcomes of Care for 1,892 Doula-Supported Adolescent Births in the United States: The DONA International Data Project, 2000 to 2013.Everson, CL., Cheyney, M., Bovbjerg, ML.[2020]
20% of mothers felt unready for discharge with their infants, and having less than a high school education was a significant predictor of this feeling, indicating a potential need for additional support for less-educated mothers.
After discharge, unready mothers reported lower happiness, made more inquiries about their infants, and were more likely to place their infants in a potentially unsafe sleeping position, highlighting the importance of ensuring maternal readiness for the well-being of both mother and infant.
Postpartum discharge: do varying perceptions of readiness impact health outcomes?Bernstein, HH., Spino, C., Baker, A., et al.[2019]

References

Developing a multimodal maternal infant perinatal outpatient delivery system: the MOMI PODS program. [2023]
Outcomes of Care for 1,892 Doula-Supported Adolescent Births in the United States: The DONA International Data Project, 2000 to 2013. [2020]
Postpartum discharge: do varying perceptions of readiness impact health outcomes? [2019]
Bridging the postpartum gap: best practices for training of obstetrical patient navigators. [2023]
Delivery Strategies for Postpartum Care: A Systematic Review and Meta-analysis. [2023]
Effect of implementation of the MOREOB program on adverse maternal and neonatal birth outcomes in Ontario, Canada: a retrospective cohort study. [2020]
A systematic review of adverse events following immunization during pregnancy and the newborn period. [2021]
Evaluation of implementation outcomes of an integrated group postpartum and well-child care model at clinics in Malawi. [2023]
Evaluation of a midwifery network to guarantee outpatient postpartum care: a mixed methods study. [2020]
Telehealth Care for Mothers and Infants to Improve the Continuum of Care: Protocol for a Quasi-Experimental Study. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Dyadic Care Mobile Units: A Collaborative Midwifery and Pediatric Response to the COVID-19 Pandemic. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Creating New Strategies to Enhance Postpartum Health and Wellness. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security